Thrive Capital Management (Pennsylvania)’s Eli Lilly LLY Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.6M	Buy	3,911 +3,367	+619%	+$3.41M	0.79%	61
2025 Q4	$584K	Buy	544 +47	+9%	+$44.9K	0.13%	122
2025 Q3	$380K	Buy	497 +11	+2%	+$8.19K	0.1%	142
2025 Q2	$379K	Buy	486 +151	+45%	+$117K	0.12%	132
2025 Q1	$277K	Buy	+335	New	+$279K	0.17%	100
2024 Q4	–	Sell	-504	Closed	-$447K	–	141
2024 Q3	$447K	Buy	504 +15	+3%	+$13.5K	0.21%	131
2024 Q2	$443K	Buy	489 +3	+0.6%	+$2.4K	0.2%	133
2024 Q1	$378K	Buy	486 +51	+12%	+$36.3K	0.2%	69
2023 Q4	$254K	Buy	435 +1	+0.2%	+$584	0.14%	116
2023 Q3	$233K	Buy	+434	New	+$224K	0.13%	120

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s LLY Position: Q1 2026 in Review

Thrive Capital Management (Pennsylvania) increased its Eli Lilly (LLY) stake by 619% in Q1 2026, buying an estimated $3.41M and bringing the position to 3,911 shares worth $3.6M. The position accounts for 0.79% of the portfolio, ranked #61.

Thrive Capital Management (Pennsylvania) first reported a position in LLY in Q3 2023 and has held it in 10 quarters since. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Thrive Capital Management (Pennsylvania) held 3,911 shares of Eli Lilly worth $3.6M as of Q1 2026.
Thrive Capital Management (Pennsylvania) bought 3,367 Eli Lilly shares in Q1 2026, an estimated $3.41M.
Eli Lilly made up 0.79% of Thrive Capital Management (Pennsylvania)'s portfolio in Q1 2026, its #61 holding.
Thrive Capital Management (Pennsylvania) first reported a position in Eli Lilly in Q3 2023 and has held it in 10 quarters since.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q1 2026, filed 27 Apr 2026.